Complex | |
AACDB_ID: | 6097 |
PDBID: | 8E7M |
Chains: | HL_A |
Organism: | Homo sapiens |
Method: | EM |
Resolution (Å): | 3.30 |
Reference: | 10.1101/2022.08.24.505169 |
Antibody | |
Antibody: | 05B04 Fab |
Antibody mutation: | No |
INN (Clinical Trial): | |
Antigen | |
Antigen: | Human angiotensin-converting enzyme 2 |
Antigen mutation: | No |
Durg Target: | Q9BYF1 |
Antibody
Heavy Chain: H
Mutation: NULL
>8E7M_H|Chain B[auth H]|05B04 Heavy Chain|Homo sapiens (9606) EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGDRTYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDWAMVGADAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKT |
Light Chain: L
Mutation: NULL
>8E7M_L|Chain C[auth L]|05B04 Light Chain|Homo sapiens (9606) DIQMTQSPSAMSASVGDRVTITCRASQGISNYFAWFQQKPGKVPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISNLQPEDFATYYCLQHSYYPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
Antigen
Chain: A
Mutation: NULL
>8E7M_A|Chain A|Angiotensin-converting enzyme 2|Homo sapiens (9606) MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADGSGHHHHHHHH |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
H: GLY53 ASP56 ARG57 TYR59 TRP100 ALA101 MET102 VAL103 GLY104 L: SER30 TYR32 HIS91 SER92 TYR93 TYR94 TYR96 A: ALA17 GLN18 SER19 THR20 ILE21 GLU23 GLN24 LYS26 THR27 PHE28 ASP30 LYS31 LEU79 MET82 TYR83 GLU87 GLN89 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)